Indian pharmaceutical plans to manufacture 600 million Johnson & Johnson’s Covid-19 vaccine doses annually
Managing Director of Indian pharmaceutical company Biological E Ltd on Wednesday told Reuters that the company is looking to contract-manufacture around 600 million Johnson and Johnson's Covid-19 vaccine doses per year. Managing Director of Biological E Mahima Datla said: "We...